This inventor holds 4 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents. Top assignee: The Hospital for Sick Children. Active years: 2008-2014.
Company Filing History:
Years Active: 2008-2014
Title: Innovations by Jeffrey R. Gingrich
Introduction
Jeffrey R. Gingrich is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of pain management through his innovative methods. With a total of 4 patents, his work focuses on the modification of NMDA receptors to alleviate pain.
Latest Patents
Gingrich's latest patents include a method for ameliorating pain by modification of NMDA receptors through inhibition of SRC. This invention provides a method for alleviating inflammatory and/or neuropathic pain in a subject by modifying the activity of N-methyl-D-aspartate (NMDA) receptors in cells of the subject. The method involves inhibiting the interaction of the unique domain of the tyrosine kinase Src enzyme and the NMDA receptor complex. This innovative approach aims to improve pain management strategies for patients suffering from various types of pain.
Career Highlights
Jeffrey R. Gingrich is affiliated with The Hospital for Sick Children, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on pain treatment methodologies.
Collaborations
Gingrich collaborates with Michael W. Salter, a fellow researcher in the field. Their partnership enhances the research efforts aimed at understanding and treating pain more effectively.
Conclusion
Jeffrey R. Gingrich's contributions to pain management through his innovative patents highlight the importance of research in improving healthcare outcomes. His work continues to pave the way for advancements in the treatment of pain.